Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives.
Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives.
复制标题
抗治疗精神分裂症:临床,生物学和治疗视角。
DOI:
10.1016/j.nbd.2018.08.016
复制
发表时间:
2019-11
影响因子:
6.1
通讯作者:
Sawa A
中科院分区:
文献类型:
--
作者:
Nucifora FC Jr;Woznica E;Lee BJ;Cascella N;Sawa A
Treatment resistant schizophrenia (TRS) refers to the significant proportion of schizophrenia patients who continue to have symptoms and poor outcomes despite treatment. While many definitions of TRS include failure of two different antipsychotics as a minimum criterion, the wide variability in inclusion criteria has challenged the consistency and reproducibility of results from studies of TRS. We begin by reviewing the clinical, neuroimaging, and neurobiological characteristics of TRS. We further review the current treatment strategies available, addressing clozapine, the first-line pharmacological agent for TRS, as well as pharmacological and nonpharmacological augmentation of clozapine including medication combinations, electroconvulsive therapy, repetitive transcranial magnetic stimulation, deep brain stimulation, and psychotherapies. We conclude by highlighting the most recent consensus for defining TRS proposed by the Treatment Response and Resistance in Psychosis (TRRIP) Working Group, and provide our overview of future perspectives and directions that could help advance the field of TRS research, including the concept of TRS as a potential subtype of schizophrenia.
登录
查看更多内容
影响因子:
6.6
作者:
BRENNER, HD;DENCKER, SJ;MIDHA, KK
通讯作者:
MIDHA, KK
影响因子:
2.2
作者:
Akamine, Yumiko;Sugawara-Kikuchi, Yuka;Miura, Masatomo
通讯作者:
Miura, Masatomo
影响因子:
6.7
作者:
Brown AS
通讯作者:
Brown AS
DOI:
10.1073/pnas.97.14.8104
发表时间:
2000-07-05
影响因子:
11.1
作者:
Abi-Dargham, A;Rodenhiser, J;Laruelle, M
通讯作者:
Laruelle, M
影响因子:
3.8
作者:
Cramer, JA;Rosenheck, R
通讯作者:
Rosenheck, R